Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-042148
Filing Date
2004-03-15
Accepted
2004-03-15 15:35:37
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2003 d10k.htm 10-K 877135
3 2000 EQUITY INCENTIVE PLAN, AS AMENDED dex102.htm EX-10.2 88213
4 LIST OF SUBSIDIARY dex21.htm EX-21 1437
5 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS dex231.htm EX-23.1 1930
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14 dex311.htm EX-31.1 9172
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14 dex312.htm EX-31.2 9398
8 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 USC SECTION 1350 dex32.htm EX-32 4614
  Complete submission text file 0001193125-04-042148.txt   994169
Mailing Address
Business Address 3005 FIRST AVENUE SEATTLE WA 98121 206254545
DENDREON CORP (Filer) CIK: 0001107332 (see all company filings)

EIN.: 223203193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30681 | Film No.: 04669394
SIC: 2834 Pharmaceutical Preparations